Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 3Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia 3Carcinoma, Non-Small-Cell Lung 3Neoplasms by Histologic Type 2Myeloproliferative Disorders 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid 2Hematologic Diseases 2Bone Marrow Diseases 2Small Cell Lung Carcinoma 1Piebaldism 1Malignant Hepatobiliary Neoplasm 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Immunoproliferative Disorders 1Immune System Diseases 1Hematologic Neoplasms 1Glioblastoma 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 341Paclitaxel 262Cisplatin 233Pemetrexed 226Docetaxel 206Erlotinib Hydrochloride 193Gemcitabine 178pembrolizumab 137Bevacizumab 121Radiotherapy 118Nivolumab 84Gefitinib 73Vinorelbine 64Cetuximab 58atezolizumab 47Afatinib 46durvalumab 44osimertinib 41Radiosurgery 35Ipilimumab 34Drug Therapy 32Taxes 30Albumin-Bound Paclitaxel 29130-nm albumin-bound paclitaxel 29Surgical Procedures, Operative 28Etoposide 25Irinotecan 24Sorafenib 21Cyclophosphamide 20Radiation 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Non-Small-Cell Lung × ponatinib × Clear all
NCT03704688 2025-05-16

Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
12 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01935336 2022-02-11

Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers

University of Colorado, Denver

Phase 2 Completed
171 enrolled 13 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT01813734 2019-12-24

Ponatinib in Advanced NSCLC w/ RET Translocations

Massachusetts General Hospital

Phase 2 Completed
9 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡